Kröll-Seger Judith, Bien Christian G, Huppertz Hans-Jürgen
Swiss Epilepsy Center, Bleulerstrasse 60, 8008 Zurich, Switzerland.
Epileptic Disord. 2009 Mar;11(1):54-9. doi: 10.1684/epd.2009.0237. Epub 2009 Mar 2.
Limbic encephalitis (LE) is increasingly recognized as a precipitating factor of adult onset temporal lobe epilepsy frequently associated with bilateral hippocampal damage. So far, clinical data in children are rare and only comprise paraneoplastic forms of LE. We describe a 13-year-old pre-pubertal girl in whom non-paraneoplastic LE was diagnosed according to diagnostic criteria proposed by Bien and Elger (2007). The girl presented with a subacute syndrome comprising memory impairment, affective disturbances, and refractory temporal lobe seizures. Serial MRI scans demonstrated an initial temporo-medial swelling with T2/FLAIR signal increase progressing to bilateral hippocampal atrophy within seven months. Two years after onset of symptoms, antibodies to potassium channels were found to be slightly elevated. Immunosuppressive therapy with steroid-pulses was followed by a transient reduction of seizure frequency, even though this was started more than two years after onset of first symptoms. However, extended immunotherapy was refused by the patient's parents, so no full assessment of the treatment response was possible. In conclusion, this case shows that non-paraneoplastic LE leading to mesial temporal lobe epilepsy is not restricted to adult patients. The proposed diagnostic criteria therefore should be adapted for paediatric patients. Patients may profit from immunosuppressive therapy even when it is started at a late stage with already overt hippocampal sclerosis.
边缘叶性脑炎(LE)越来越被认为是成人发作性颞叶癫痫的一个促发因素,常与双侧海马损伤相关。到目前为止,儿童的临床数据很少,且仅包括副肿瘤性LE形式。我们描述了一名13岁青春期前女孩,根据Bien和Elger(2007年)提出的诊断标准诊断为非副肿瘤性LE。该女孩表现为一种亚急性综合征,包括记忆障碍、情感障碍和难治性颞叶癫痫发作。连续的MRI扫描显示最初颞叶内侧肿胀,T2/FLAIR信号增强,在七个月内进展为双侧海马萎缩。症状出现两年后,发现钾通道抗体略有升高。采用类固醇脉冲进行免疫抑制治疗后癫痫发作频率短暂降低,尽管这是在首次症状出现两年多后开始的。然而,患者父母拒绝了延长免疫治疗,因此无法对治疗反应进行全面评估。总之,该病例表明导致内侧颞叶癫痫的非副肿瘤性LE并不局限于成年患者。因此,所提出的诊断标准应适用于儿科患者。即使在晚期海马硬化已经明显时开始免疫抑制治疗,患者也可能从中获益。